Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy

Hongying Sui, Caixia Shi, Zhiping Yan, Hucheng Li
  • Drug Design Development and Therapy, June 2015, Dove Medical Press
  • DOI: 10.2147/dddt.s82035

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/dddt.s82035

The following have contributed to this page: Dr Hongying Sui

In partnership with: